Lumibird SA (EPA: LBIRD)
France
· Delayed Price · Currency is EUR 7.30
0.00 (0.00%)
Nov 22, 2024, 5:35 PM CET
Lumibird Revenue
Lumibird had revenue of 99.24M EUR in the half year ending June 30, 2024, with 15.09% growth. This brings the company's revenue in the last twelve months to 207.33M, up 0.39% year-over-year. In the year 2023, Lumibird had annual revenue of 206.55M with 6.31% growth.
Revenue (ttm)
207.33M
Revenue Growth
+0.39%
P/S Ratio
0.77
Revenue / Employee
196.90K
Employees
989
Market Cap
160.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 206.55M | 12.26M | 6.31% |
| Dec 31, 2022 | 194.29M | 27.91M | 16.77% |
| Dec 31, 2021 | 166.39M | 36.88M | 28.48% |
| Dec 31, 2020 | 129.51M | 16.85M | 14.96% |
| Dec 31, 2019 | 112.65M | 10.86M | 10.67% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.74B |
| bioMérieux S.A. | 3.81B |
| Ipsen S.A. | 3.44B |
| Eurofins Scientific SE | 6.72B |
| Virbac SA | 1.34B |
| Ramsay Générale de Santé SA | 5.01B |